Science & practice perspectives / a publication of the National Institute on Drug Abuse, National Institutes of Health
about
12-step participation as a pathway to recovery: the Maryhaven experience and implications for treatment and researchThe neurobiology of cocaine addictionOne program's transition to research-based strategies for treating methamphetamine abuse.Residential treatment for parents and their children: the Village experienceImaging the addicted human brainCommunity coalitions and prevention: a panel discussionPractical considerations for the clinical use of buprenorphine.Response: families, models, relationships.Behavioral couples therapy for substance abuse: rationale, methods, and findings.Response: treatment in transitionMood disorders and substance use disorder: a complex comorbidityMethadone treatment at fortyStakeholders in recovery: demands, expectations, and research opportunities.Research-practice partners assess their first joint projectTargeting nicotine addiction in a substance abuse program.Integrating substance abuse treatment and criminal justice supervision.Fishbowls and candy bars: using low-cost incentives to increase treatment retentionResponse: the marriage of drug abuse treatment and 12-step strategies.Response: adolescent substance abuse patients: resilience and complexity.HIV/hepatitis prevention in drug abuse treatment programs: guidance from researchTreating women drug abusers: action therapy and trauma assessment.Dialogue and collaboration: a path for progress.Two perspectives, one goalResponse: treating women on their own terms.Using behavioral reinforcement to improve methadone treatment participationConnecticut partnership targets substance-abusing parents.Treatment practice and research issues in improving opioid treatment outcomes.Quality and performance improvement: what's a program to do?Attending to emotional cues for drug abuse: bridging the gap between clinic and home behaviors.Assessing organizational functioning as a step toward innovationA note from NIDA's director. Images and interventions.Response: disconnects, triggers, and two-edged swords.Response: TIPsters weigh in: putting good science to work.Response: setting the stage for improvement and accountabilityThe neurobiology of opioid dependence: implications for treatment.Community treatment programs take up buprenorphine.Response: integrating buprenorphine therapy into clinical practiceResponse: Still room to improve an effective treatment.Response: The path to double recovery.Response: The healing power of information.
P1433
Q24602280-9FBEB815-3427-434A-892B-2167452E2C37Q24602314-6124094D-912E-4598-8561-ED011F324854Q30361813-DCD72A5C-F24D-484A-A9DD-6C21C5764A26Q30369960-F5F7BA01-3C32-49EC-BC30-08885CD96EDCQ31113208-349C4D8D-8AFB-45CB-9DAA-3AC3FF403E0CQ33774847-7335D5BF-C340-435F-9033-883AE8F86E4EQ33774853-F9461458-0395-43A4-BFEA-76CD661110A2Q33774870-11790B9A-3483-415A-B1F6-5719052ECFA0Q33774878-685B9A5C-9215-433F-8AEB-A2BE785865E1Q33774886-C03BEC56-DA0A-4B24-A14D-13E68E4EBFCCQ33774896-3C0B5C48-4ECB-48A0-A015-4A24E927AAFEQ33774901-C29D62FA-2A5E-46D8-A0CB-882BA81DD14EQ33774922-E0CB9E0A-3AAE-490E-8679-A8F7224C492AQ33774927-B7BA40A6-2AD5-4663-B1AF-65F1BFBC0A3EQ33774943-092CB042-8BC9-48F9-9555-8833310291B5Q33774950-B21D4608-4E2C-4DCC-A024-4F893D5F160FQ33774954-9B4020FA-2518-492A-858B-6EDDF121D854Q33774959-91D6BB86-30A2-47F8-89EA-0ADC06AD19D8Q33774971-7A4B20BE-C03A-4608-8DD9-70DC1FE747E9Q33774978-ABB15638-13FB-45D2-ABB4-D8AE8C65D881Q33774984-6FCBF980-0A3C-4E7C-9324-F3490D6BA3C8Q33774993-85849412-FA7E-4CDB-9B20-1E3382320F2BQ33775006-70E4112B-90E4-459E-84AF-053DBB0B29C0Q33775012-FC8B1E87-2184-496C-9EE3-1BA796400C24Q33775019-B4320D85-A0DA-4D69-A956-6B5BBB438CB7Q33775023-0D0B6C2F-DC9D-49B7-9E3A-7395ACF69D5CQ33775030-2C95C9AB-6F51-4932-A89A-35AE35F1A688Q33775035-1E21D462-3F61-4E94-AF41-B444F9F12CECQ33775043-1836BBEF-2D80-4F5C-B1B2-FCA252AD7DB5Q33775056-CB1032B8-75B4-4F34-AA66-921986323DBCQ33775061-D12B4728-AACC-468A-ACF6-34F7BB506917Q33775069-5B79F525-7AA3-47C1-A775-2D4653FDB359Q33775081-C2AD0091-1D0F-4BE1-A08C-4246633A98B5Q33775088-4A87E806-EF03-49E4-B443-83CFED18C903Q34787830-30A68E2C-3849-44B2-BC13-670B8EA57C28Q39938477-02ABBDE1-CC94-4D13-A2F1-8A84C85001F7Q39938606-DB1C69CC-E014-467B-980C-07679F682500Q39938673-B6BF0178-A4FF-457A-93D4-258CC5929AC1Q39938723-3DB90C48-ED9C-4275-9C35-19D33E2C6CC0Q39938804-D2FDC4F7-E79F-4D0E-A332-83B168BA6D9F
P1433
Science & practice perspectives / a publication of the National Institute on Drug Abuse, National Institutes of Health
description
journal
@en
revista científica
@es
rivista scientifica
@it
wetenschappelijk tijdschrift
@nl
wissenschaftliche Fachzeitschrift
@de
name
Science & practice perspective ...... National Institutes of Health
@ast
Science & practice perspective ...... National Institutes of Health
@en
Science & practice perspective ...... National Institutes of Health
@es
Science & practice perspective ...... National Institutes of Health
@it
Science & practice perspective ...... National Institutes of Health
@nl
type
label
Science & practice perspective ...... National Institutes of Health
@ast
Science & practice perspective ...... National Institutes of Health
@en
Science & practice perspective ...... National Institutes of Health
@es
Science & practice perspective ...... National Institutes of Health
@it
Science & practice perspective ...... National Institutes of Health
@nl
prefLabel
Science & practice perspective ...... National Institutes of Health
@ast
Science & practice perspective ...... National Institutes of Health
@en
Science & practice perspective ...... National Institutes of Health
@es
Science & practice perspective ...... National Institutes of Health
@it
Science & practice perspective ...... National Institutes of Health
@nl
P3181
P1055
P1156
10300153359